Genovis AB (publ.) Statistics

Total Valuation

STO:GENO has a market cap or net worth of SEK 1.57 billion. The enterprise value is 1.48 billion.

Market Cap	1.57B
Enterprise Value	1.48B

Important Dates

The last earnings date was Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:GENO has 65.47 million shares outstanding.

Current Share Class	65.47M
Shares Outstanding	65.47M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.06%
Owned by Institutions (%)	53.45%
Float	55.61M

Valuation Ratios

The trailing PE ratio is 47.73 and the forward PE ratio is 54.96. STO:GENO's PEG ratio is 1.48.

PE Ratio	47.73
Forward PE	54.96
PS Ratio	11.96
PB Ratio	6.89
P/TBV Ratio	7.12
P/FCF Ratio	43.61
P/OCF Ratio	42.33
PEG Ratio	1.48

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 36.97, with an EV/FCF ratio of 41.03.

EV / Earnings	44.91
EV / Sales	11.26
EV / EBITDA	36.97
EV / EBIT	50.04
EV / FCF	41.03

Financial Position

The company has a current ratio of 7.38, with a Debt / Equity ratio of 0.34.

Current Ratio	7.38
Quick Ratio	6.77
Debt / Equity	0.34
Debt / EBITDA	1.92
Debt / FCF	2.13
Interest Coverage	7.44

Financial Efficiency

Return on equity (ROE) is 15.72% and return on invested capital (ROIC) is 6.41%.

Return on Equity (ROE)	15.72%
Return on Assets (ROA)	5.97%
Return on Invested Capital (ROIC)	6.41%
Return on Capital Employed (ROCE)	9.84%
Revenue Per Employee	4.10M
Profits Per Employee	1.03M
Employee Count	32
Asset Turnover	0.43
Inventory Turnover	1.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.94% in the last 52 weeks. The beta is 1.93, so STO:GENO's price volatility has been higher than the market average.

Beta (5Y)	1.93
52-Week Price Change	-18.94%
50-Day Moving Average	21.62
200-Day Moving Average	24.51
Relative Strength Index (RSI)	63.94
Average Volume (20 Days)	82,990

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:GENO had revenue of SEK 131.32 million and earned 32.92 million in profits. Earnings per share was 0.50.

Revenue	131.32M
Gross Profit	115.22M
Operating Income	29.45M
Pretax Income	46.33M
Net Income	32.92M
EBITDA	33.43M
EBIT	29.45M
Earnings Per Share (EPS)	0.50

Full Income Statement

Balance Sheet

The company has 169.44 million in cash and 76.60 million in debt, giving a net cash position of 92.84 million or 1.42 per share.

Cash & Cash Equivalents	169.44M
Total Debt	76.60M
Net Cash	92.84M
Net Cash Per Share	1.42
Equity (Book Value)	227.97M
Book Value Per Share	3.48
Working Capital	179.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 37.12 million and capital expenditures -1.09 million, giving a free cash flow of 36.03 million.

Operating Cash Flow	37.12M
Capital Expenditures	-1.09M
Free Cash Flow	36.03M
FCF Per Share	0.55

Full Cash Flow Statement

Margins

Gross margin is 87.74%, with operating and profit margins of 22.42% and 25.07%.

Gross Margin	87.74%
Operating Margin	22.42%
Pretax Margin	35.28%
Profit Margin	25.07%
EBITDA Margin	25.46%
EBIT Margin	22.42%
FCF Margin	27.44%

Dividends & Yields

STO:GENO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.09%
FCF Yield	2.29%

Stock Splits

The last stock split was on April 4, 2012. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 4, 2012
Split Type	Reverse
Split Ratio	0.1

Scores

STO:GENO has an Altman Z-Score of 13.83.

Altman Z-Score	13.83
Piotroski F-Score	n/a